Clinical Trial Update: Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update describing a psilocybin-assisted psychotherapy study for treatment-resistant depression with co-occurring substance use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Use Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Indiana University | Conditions: Treatment Resistant Depression, Substance Use Disorders | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING